Northwise Company Research
AbCellera
ABCLHealthcare & Life Sciences · Health & Life Sciences Innovation
Follow ABCLStart with Free research
Get to know the business before exploring its models and valuation.
Market Price
$12.63
End-of-day price · Oct 12, 2026
Northwise Valuation
Premium investment conclusions
Northwise currently covers this company through research. A current Northwise model, price target, expected CAGR, and rating have not been published.
Research Note · Free
Published
Abcl stock analysis exploring AbCellera’s discovery engine, business model, and why the company remains a unique long term biotech opportunity.
Research Note · Free
Published
AbCellera Stock is reengineering antibody drug discovery from the ground up with a powerful, AI-native platform built for scale.
